We are live on ! Find out more
HEPA

Hepion Pharmaceuticals
HEPA

Delisted

HEPA was delisted on the 12th of May, 2025.

Back to rankings

4 hedge funds and large institutions have $1.3M invested in Hepion Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 5 → 4 (-1)

48% less capital invested

Capital invested by funds: $2.49M → $1.3M (-$1.19M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$446K
2
PIA
Phoenix Investment Adviser
New York
-$36K
3
CC
Cornerstone Capital
California
-$10K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$8K
5
ISL
Ingalls & Snyder LLC
New York
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$596K – – –
HighTower Advisors
2
HighTower Advisors
Illinois
$244K – – –
Barclays
3
Barclays
United Kingdom
$125K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$72K – – –
JP Morgan Chase
5
JP Morgan Chase
New York
$46K – – –
PFS
6
Prospera Financial Services
Texas
$38K – – –
CS
7
Credit Suisse
Switzerland
$35K – – –
Citadel Advisors
8
Citadel Advisors
Florida
$31K – – –
Northern Trust
9
Northern Trust
Illinois
$26K – – –
Morgan Stanley
10
Morgan Stanley
New York
$15K – – –
PAG
11
Private Advisor Group
New Jersey
$14K – – –
Bank of Montreal
12
Bank of Montreal
Ontario, Canada
$12K – – –
BlackRock
13
BlackRock
New York
$11K – – –
Bank of New York Mellon
14
Bank of New York Mellon
New York
$9K – – –
TSS
15
Two Sigma Securities
New York
$8K – – –
LPL Financial
16
LPL Financial
California
$4K – – –
RJFSA
17
Raymond James Financial Services Advisors
Florida
$4K – – –
USAA
18
United Services Automobile Association
Texas
$4K – – –
UBS Group
19
UBS Group
Switzerland
$2K – – –
VF
20
Virtu Financial
New York
$2K – – –
BWA
21
BDO Wealth Advisors
Florida
$1K – – –
IWM
22
IHT Wealth Management
Illinois
$1K – – –
Wells Fargo
23
Wells Fargo
California
$1K – – –
AFM
24
Anson Funds Management
Texas
– -$446K -2 Closed
CC
25
Cornerstone Capital
California
– -$10K – –
1
2

HEPA Hedge Fund Activity: Q1 2018 in Review

4 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Hepion Pharmaceuticals (HEPA) for Q1 2018, worth a combined $1.3M — down 48% from $2.49M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of HEPA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Anson Funds Management, exiting entirely with an estimated $446K sold.

  • 4 institutional investors held Hepion Pharmaceuticals (HEPA) as of Q1 2018, down from 5 in Q4 2017.
  • Funds reported $1.3M of Hepion Pharmaceuticals stock for Q1 2018, down 48% quarter-over-quarter.
  • 0 funds opened new Hepion Pharmaceuticals positions in Q1 2018 and 1 closed out, a net change of -1 holder.
  • The largest Hepion Pharmaceuticals seller in Q1 2018 was Anson Funds Management, an estimated $446K sold.

Based on aggregated 13F filings for Q1 2018.